Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Lara Batičić
Diabetes Mellitus and DPP IV/CD26 Inhibitors
Medicina Fluminensis
Medicine
Related publications
Dipeptidyl Peptidase 4 (Dpp-4) Inhibitors for the Treatment of Type 2 Diabetes Mellitus
Journal of thee Medical Sciences (Berkala Ilmu Kedokteran)
Dipeptidyl Peptidase-4 (DPP-4; CD26)
Science-Business eXchange
Rapid Isolation of Endosomes From BHK Cells: Identification of DPP IV (CD26) in Endosomes
Experimental Cell Research
Cell Biology
Systematic Literature Review of DPP-4 Inhibitors in Patients With Type 2 Diabetes Mellitus and Renal Impairment
Diabetes Therapy
Internal Medicine
Endocrinology
Metabolism
Diabetes
Prescription of DPP-4 Inhibitors to Type 2 Diabetes Mellitus Patients With Renal Impairment: A UK Primary Care Experience
Clinical Therapeutics
Pharmacology
Emerging DPP-4 Inhibitors: Focus on Linagliptin for Type 2 Diabetes
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy
Internal Medicine
Pharmacology
Clinicians Should Think Twice Before Prescribing DPP-4 Inhibitors for Diabetes
Evidence-Based Medicine
Medicine
Use of DPP-4 Inhibitors in Type 2 Diabetes: Focus on Sitagliptin
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy
Internal Medicine
Pharmacology
Pdb81 - Dapagliflozin Is Cost-Effective Compared to DPP-4 Inhibitors in the Treatment of Type 2 Diabetes Mellitus in the Netherlands
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental